BEIJING, Aug. 8, 2022
/PRNewswire/ -- WeTrade Group Inc. (NASDAQ: WETG), an emerging
growth company engaged in the business of providing
software-as-a-services (SAAS) and cloud intelligent systems for
micro-businesses, completed an in-depth discussion of the strategic
partnership with Jiqing Biomedical Technology Co. Ltd recently. The
companies will sign the official contract soon and Wetrade will
take the exclusive sale channel for Jiqing's monkeypox virus test
kits globally.
Jiqing, a medical company that has been at the top of the
medical industry in China, has
changed its development strategy to overseas markets. From the
COVID-19 antigen test kits to monkeypox test kits, Jiqing has
consolidated the overseas market step by step. Jiqing expects to
benefit from the advanced technology and international market
channels through partnering with Wetrade.
As a global-oriented development enterprise, Wetrade has been
working on discovering overseas business for domestic companies.
Wetrade believes that building its own private domain traffic would
help Chinese companies carry out business operations in overseas
markets easier. In the meantime, it would empower those
companies to increase product awareness rapidly, find targeted
audiences accurately and accumulate customers efficiently.
The cooperation with Jiqing is a great opportunity to enter the
medical industry, as another breakthrough. However, relying on its
technology and operation ability accumulated in domestic and
international markets, Wetrade has the capability to expand western
market for Jiqing and utilize the private domain to reach terminal
consumers by social fission, to save distribution costs for Jiqing
and help maximize the company's profit.
Mr. Pijun Liu, Chief Executive Officer of Wetrade, said: "
Working with Jiqing is not only for the profit, but it is a
prominent occasion for customer base expansion. We are looking
forward to attracting more customers from different industry to use
our channel and private domain marketing promotion, to help them
avoid the domestic competitiveness and develop overseas markets
with differentiated thinking."
About WeTrade Group Inc.
WeTrade Group Inc. is a technical service provider of SAAS and
Cloud Intelligent System for micro-businesses, and a pioneering
internationalized system in the global micro-business cloud
intelligence field and the leader, innovator and promoter of the
world's cloud intelligent system for micro-businesses. WeTrade
Group independently developed the cloud intelligent system for
micro-businesses (Abbreviation: YCloud). YCloud strengthens users'
marketing relationship and CPS commission profit management through
leading technology and big data analysis. It also helps increase
the payment scenario to increase customers' revenue by
multi-channel data statistics, AI fission and management as well as
improved supply chain system. As of today, YCloud's business has
successfully landed in mainland China and Hong
Kong, covering the micro business industry, tourism
industry, hospitality industry, livestreaming and short video
industry, aesthetic medical industry and traditional retail
industry. For more information, please visit
https://ir.wetg.group.
View original
content:https://www.prnewswire.com/news-releases/wetrade-group-intends-to-enter-exclusive-strategic-partnership-with-jiqing-bio-regarding-exclusive-monkeypox-test-kits-sales-channel-globally-301601490.html
SOURCE WeTrade Group INC